Can-Fite BioPharma Ltd. (CANF) SEC Filings https://ir.canfite.com/sec-filings/all-sec-filings/rss Can-Fite BioPharma Ltd. (CANF) - All SEC Filings en-us https://d1io3yog0oux5.cloudfront.net/canfite/files/theme/images/logo-sm.png Can-Fite BioPharma Ltd. Logo Equisolve Investor Relations Suite <![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]> https://ir.canfite.com/sec-filings/all-sec-filings/content/0001213900-26-058094/0001213900-26-058094.pdf Mon, 18 May 26 07:02:36 -0400 https://ir.canfite.com/sec-filings/all-sec-filings/content/0001213900-26-058094/0001213900-26-058094.pdf <![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]> https://ir.canfite.com/sec-filings/all-sec-filings/content/0001213900-26-055438/0001213900-26-055438.pdf Wed, 13 May 26 07:06:19 -0400 https://ir.canfite.com/sec-filings/all-sec-filings/content/0001213900-26-055438/0001213900-26-055438.pdf <![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]> https://ir.canfite.com/sec-filings/all-sec-filings/content/0001213900-26-049750/0001213900-26-049750.pdf Thu, 30 Apr 26 08:39:08 -0400 https://ir.canfite.com/sec-filings/all-sec-filings/content/0001213900-26-049750/0001213900-26-049750.pdf <![CDATA[6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]]]> https://ir.canfite.com/sec-filings/all-sec-filings/content/0001213900-26-047088/0001213900-26-047088.pdf Thu, 23 Apr 26 16:20:55 -0400 https://ir.canfite.com/sec-filings/all-sec-filings/content/0001213900-26-047088/0001213900-26-047088.pdf <![CDATA[3 - Initial statement of beneficial ownership of securities]]> https://ir.canfite.com/sec-filings/all-sec-filings/content/0001213900-26-046880/0001213900-26-046880.pdf Thu, 23 Apr 26 08:00:01 -0400 https://ir.canfite.com/sec-filings/all-sec-filings/content/0001213900-26-046880/0001213900-26-046880.pdf <![CDATA[3 - Initial statement of beneficial ownership of securities]]> https://ir.canfite.com/sec-filings/all-sec-filings/content/0001213900-26-040473/0001213900-26-040473.pdf Mon, 06 Apr 26 16:16:24 -0400 https://ir.canfite.com/sec-filings/all-sec-filings/content/0001213900-26-040473/0001213900-26-040473.pdf <![CDATA[EFFECT - Notice of Effectiveness]]> https://ir.canfite.com/sec-filings/all-sec-filings/content/9999999995-26-001089/9999999995-26-001089.pdf Mon, 06 Apr 26 06:01:47 -0400 https://ir.canfite.com/sec-filings/all-sec-filings/content/9999999995-26-001089/9999999995-26-001089.pdf <![CDATA[424B3 - Prospectus [Rule 424(b)(3)]]]> https://ir.canfite.com/sec-filings/all-sec-filings/content/0001213900-26-040022/0001213900-26-040022.pdf Fri, 03 Apr 26 17:07:52 -0400 https://ir.canfite.com/sec-filings/all-sec-filings/content/0001213900-26-040022/0001213900-26-040022.pdf <![CDATA[CORRESP - Correspondence]]> https://ir.canfite.com/sec-filings/all-sec-filings/content/0001213900-26-038553/0001213900-26-038553.pdf Fri, 01 May 26 13:42:52 -0400 https://ir.canfite.com/sec-filings/all-sec-filings/content/0001213900-26-038553/0001213900-26-038553.pdf <![CDATA[UPLOAD - SEC-generated letter]]> https://ir.canfite.com/sec-filings/all-sec-filings/content/0000000000-26-003263/0000000000-26-003263.pdf Fri, 01 May 26 13:42:50 -0400 https://ir.canfite.com/sec-filings/all-sec-filings/content/0000000000-26-003263/0000000000-26-003263.pdf